USP10 and colorectal carcinoma: To investigate the extent of regulation of the WNT effector β-Catenin by USP10, and using a gain-of-function approach, we conditionally overexpressed either wild type (USP10WT) or a catalytic inactive variant of USP10 (USP10CA) in the CRC line HT-29.